Loading…
Annexon, Inc.
Annexon, Inc. (ANNX) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Brisbane, United States and has 92 employees. The company is worth $722.3M. The share price is 46.9% below its 52-week high of $7.18. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $7.9M. In that quarter, 1 of them reduced the position. Over the last 30 days, company insiders bought $99.83K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -79.1% over 5Y.
today you would have $209.07▼ -79.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 6 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $5.02 | $5.13 | $4.54 | $5.17 | $11.49 | $25.03 | |
| P/B | 1.9x | 3.5x | 1.9x | 1.4x | 1.1x | 1.9x | 2.8x |
| EPS | -$1.34 | -$1.01 | -$1.77 | -$2.60 | -$3.40 | -$4.15 | |
| ROE | -54.89% | -97.66% | -47.15% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| GERNGeron Corp | $1.13 | — | 3.3x | 0.00% | -28.28% | $725.99M |
| OBXObsidian Therapeutics, Inc. | $11.77 | — | — | 0.00% | — | $727.07M |
| ANLAdlai Nortye Group Ltd. | $11.03 | — | 3.3x | 0.00% | -20.23% | $710.31M |
| SANASana Biotechnology, Inc. | $2.37 |
| -53.58% |
| -61.40% |
| -56.20% |
| -18.42% |
Median of the years shown; P/E years above 200x are left out.
| — |
| 4.6x |
| 0.00% |
| -152.87% |
| $709.48M |
| CTKBCytek Biosciences, Inc. | $5.43 | — | 2.2x | 0.00% | -23.04% | $705.81M |
| APMDApnimed, Inc. | $17.76 | 2.5x | — | 0.00% | — | $739.36M |